Extra Strength Tylenol caplets recalled from one lot for defective container
Kenvue Brands is recalling 3,816 bottles of Extra Strength TYLENOL 500mg caplets, 24-count, from one lot because of a defective container.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Scored 2 as a packaging problem: the record cites a defective container without describing a hazard or reporting harm.
Plain-English summary
TYLENOL Acetaminophen Extra Strength, 24 caplets of 500mg each, distributed by Johnson & Johnson Consumer Inc. McNeil Consumer Healthcare Division of Fort Washington, Pennsylvania, is being recalled for a defective container.
The recall covers 3,816 bottles from lot EJA022, expiring 30 April 2028, carrying NDC 50580-378-04. The product was distributed in Colorado, Illinois, Ohio and Indiana. The FDA has classified the recall as Class II.
The enforcement record states the container defect without describing its nature or a health consequence, and reports no injuries.
Anyone holding a bottle from the affected lot should follow the retailer's instructions.
The recalled product
- Product
- TYLENOL EXTRA STRENGTH (ACETAMINOPHEN)
- Brand
- TYLENOL EXTRA STRENGTH
- Manufacturer
- Kenvue Brands LLC
- Category
- Drug — Analgesic
- Hazard
- defective-container
- packaging-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: EJA022
- expiry: 04/30/2028
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- ModerateQuality Choice Earwax Removal Kit Carbamide Peroxide Subpotent Drug Recall
FDA (Drugs) · 2026-07-22
- ModerateFamily Wellness Carbamide Peroxide Earwax Removal Kit Subpotent Drug
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22